NCT00554710 - Top Down Versus Step Up Strategies in Crohn's Disease | Biotech Hunter

Enrollment

129

Participants

Timeline

Start Date

May 31, 2001

Study Completion Date

January 31, 2004

Conditions

Crohn's Disease

Interventions

DRUG

infliximab+azathioprine

infliximab 5 mg/kg at week 0,2 and 6 + azathioprine 2-2.5 mg/kg

DRUG

methylprednisolone or budesonide

methylprednisolone 32 mg followed by taper or budesonide 9 mg/day followed by taper

Trial Locations (1)

Imelda GI Clinical Research Center, Bonheiden